Patent Term Extension Denied for Combination Drug
In The Arnold Partnership v. Dudas, 2004 WL 574480, CV-03-1339 (Fed. Cir. March 24, 2004), the Federal Circuit affirmed the district court's denial of a term extension for the drug marketed under the name Vicoprofen.
This premium content is locked for The Intellectual Property Strategist subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN The Intellectual Property Strategist
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.